Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Tritace 10mg


Contraindicated

Contraindicated
Tritace 10mg :
Type Medicine Authorised
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Aventis Deutschland GmbH
Origin Germany
Manufacturer Sanofi SpA
Origin Italy
ATC C09AA05

Your comment will appear shortly after approval

Tritace 10mg :

Revision Date : 08/12/2016


Effect Frequency
Abdominal discomfort Common
Abdominal pain upper Uncommon
Acute hepatic failure Not known
Ageusia (Taste loss) Uncommon
Agranulocytosis Rare
Alopecia Not known
Anaphylactic reactions Not known
Anaphylactoid reactions Not known
Angina pectoris Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Anorexia Uncommon
Antinuclear antibody (ANA) increased Not known
Anxiety Uncommon
Aphthous stomatitis Not known
Arrhythmia Uncommon
Arthralgia (Pain joint) (Joint ache) Uncommon
Asthenia Rare
Asthma aggravated Uncommon
Balance disorder Rare
Bilirubin conjugated increased Uncommon
Blood creatinine increased Uncommon
Blood potassium increased Common
Blood sodium decreased Not known
Blood urea increased Uncommon
Bone marrow failure Not known
Bronchitis Common
Bronchospasm Uncommon
Burning sensation Not known
Cerebral ischaemia Not known
Chest pain Common
Confusional state Rare
Conjunctivitis Rare
Constipation Uncommon
Cytolytic hepatitis Not known
Decreased appetite Uncommon
Depressed mood Uncommon
Dermatitis exfoliative Rare
Dermatitis psoriasiform Not known
Diarrhoea (Diarrhea) Common
Digestive disorder Common
Dizziness Common
Dry cough (Non-productive cough) Common
Dry mouth (Xerostomia) Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Uncommon
Dyspepsia Common
Dyspnoea (dyspnea) Common
Enanthema Not known
Eosinophilia Uncommon
Eruption lichenoid (Dermatitis lichenoid) Not known
Erythema multiforme Not known
Fatigue Common
Flushing Uncommon
Gastritis Uncommon
Gastrointestinal inflammation Common
Glossitis Rare
Gynecomastia (Gynaecomastia) Not known
Haemoglobin decreased Rare
Haemolytic anemia Not known
Headache Common
Hearing impaired Rare
Hepatic enzyme increased Uncommon
Hepatitis cholestatic Not known
Hepatocellular damage Rare
Hyperhidrosis Uncommon
Hypoperfusion Rare
Hypotension Common
Impairment of attention Not known
Impotence Uncommon
Inappropriate antidiuretic hormone secretion (SIADH) Not known
Irritative cough Common
Ischaemic stroke Not known
Jaundice cholestatic (Cholestatic icterus) Rare
Leukocyte count decreased (White blood cell count decreased) Rare
Libido decreased Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Maculopapular rash Common
Muscle spasms Common
Myalgia Common
Myocardial infarction Uncommon
Myocardial ischaemia Uncommon
Nasal congestion Uncommon
Nausea Common
Nervousness Uncommon
Neutropenia Rare
Oedema peripheral Uncommon
Onycholysis Rare
Orthostatic hypotension Common
Palpitations Uncommon
Pancreatic enzymes increased Uncommon
Pancreatitis Uncommon
Pancytopenia Not known
Paraesthesia (paresthesia) Uncommon
Parosmia Not known
Pemphigoid Not known
Pemphigus Not known
Photosensitivity reaction Very rare
Platelet count decreased (Thrombocyte count decreased) Rare
Proteinuria aggravated Uncommon
Pruritus Uncommon
Psoriasis aggravated (Psoriasis flare-up) Not known
Psychomotor skills impaired Not known
Pyrexia Uncommon
Raynaud's phenomenon Not known
Red blood cell count decreased Rare
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Uncommon
Renal impairment Uncommon
Restlessness Uncommon
Sinusitis Common
Skin rash Common
Sleep disorder (Sleep disturbance) Uncommon
Small bowel angioedema Uncommon
Somnolence Uncommon
Stevens-Johnson syndrome Not known
Syncope Common
Tachycardia Uncommon
Tinnitus Rare
Transient ischaemic attack Not known
Tremor Rare
Urine output increased Uncommon
Urticaria Rare
Vascular stenosis Rare
Vasculitis Rare
Vertigo Uncommon
Vision blurred Uncommon
Visual disturbance Uncommon
Vomiting Common

Different Units By MoH Code

Revision Date : 01/06/2018

Tritace 10mg Tritace 10mg Tritace 10mg Tritace 10mg Tritace 10mg Tritace 10mg

Tritace 10mg  MoH 10885 :
Form Tablet
Packaging Blisters
Package Size Box of 28
Strength 10mg
Public Price 693242,55 L.L.
Stratum A1
NSSF ✔
Quarantine ✘
Reg. Number 26822/1
Submission date 2022
Registration Year 14/07/2022


NB : Double registration in 2022 with Different manufacturer

Price Comparison

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 28
● Public Price: 693242.55 LBP ( 693,242.55 LBP )
● Pack size unit used: 28
● Cost/Unit: 24758,66 LBP ( 24,758.00 LBP )
● Pricing Date: 10/01/2024

● Country: Qatar
● Package Size: 28
● Public Price: 120 QAR ( 498,067.20 LBP )
● Pack size unit used: 28
● Cost/Unit: 4,2857 QAR ( 16,602.24 LBP )
● Pricing Date: 28/01/2021

● Country: Abu Dhabi
● Package Size: 28
● Public Price: 118 AED ( 485,093.28 LBP )
● Pack size unit used: 28
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Pricing Date: 27/01/2021

● Country: UAE
● Package Size: 28's (14's Blister x 2)
● Public Price: 118 AED ( 485,093.28 LBP )
● Pack size unit used: 28
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Pricing Date: 21/08/2019

● Country: Sweden
● Package Size: 98
● Public Price: 268.74 SEK ( 483,761.56 LBP )
● Pack size unit used: 98
● Cost/Unit: 2,7422 SEK ( 3,600.22 LBP )
● Pricing Date: 23/04/2020

● Country: Norway
● Package Size: 98
● Public Price: 179.4 NOK ( 310,410.44 LBP )
● Pack size unit used: 98
● Cost/Unit: 1,8306 NOK ( 1,730.27 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020

● Country: Czech Republic
● Package Size: 30
● Public Price: 81.08 CZK ( 56,006.82 LBP )
● Pack size unit used: 30
● Cost/Unit: 2,7027 CZK ( 1,381.52 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020

● Country: Italy
● Package Size: 28UNITA
● Public Price: 8.04 EUR ( 147,775.60 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2871 EUR ( 0.00 LBP )
● Pricing Date: 15/01/2021

● Country: Ireland
● Package Size: 28
● Public Price: 3.36 EUR ( 61,756.97 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,12 EUR ( 0.00 LBP )
● Pricing Date: 09/10/2020

● Country: Kuweit
● Package Size: Boîte de 28
● Public Price: 8.95 KWD ( 443,652.22 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,3196 KWD ( 0.00 LBP )
● Pricing Date: 07/02/2021

● Country: Belgium
● Package Size: 28
● Public Price: 17.2 EUR ( 316,136.86 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,6143 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020

● Country: Jordan
● Package Size: 28
● Public Price: 7.63 JOD ( 162,825.65 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2725 JOD ( 0.00 LBP )
● Reference: JFDA
● Pricing Date: 25/05/2020

● Country: UK
● Package Size: 28
● Public Price: 13.68 GBP ( 275,662.53 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4886 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021

● Country: Switzerland
● Package Size: 100
● Public Price: 46.75 CHF ( 797,566.69 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,4675 CHF ( 0.00 LBP )
● Pricing Date: 04/04/2021

● Country: Bahrain
● Package Size: 28
● Public Price: 11.45 BHD ( 459,382.82 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4089 BHD ( 0.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021

● Country: Finland
● Package Size: 98
● Public Price: 13.97 EUR ( 256,769.30 LBP )
● Pack size unit used: 98
● Cost/Unit: 0,1426 EUR ( 0.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021

● Country: France
● Package Size: 30
● Public Price: 6.31 EUR ( 115,978.12 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021

● Country: Denmark
● Package Size: 98
● Reference: Danish Medicine Agency
● Pricing Date: 20/02/2019

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Heart failure :
● Cost/Unit: 24758,66 LBP ( 24,758.00 LBP )
● Cost/Day: 24758,66 LBP ( 24,758.00 LBP )
● Cost/Month: 742759,8 LBP ( 742,759.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 24758,66 LBP ( 24,758.00 LBP )
● Cost/Day: 24758,66 LBP ( 24,758.00 LBP )
● Cost/Month: 742759,8 LBP ( 742,759.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 24758,66 LBP ( 24,758.00 LBP )
● Cost/Day: 24758,66 LBP ( 24,758.00 LBP )
● Cost/Month: 742759,8 LBP ( 742,759.00 LBP )
Heart failure :
● Cost/Unit: 4,2857 QAR ( 16,602.24 LBP )
● Cost/Day: 4,29 QAR ( 16,602.24 LBP )
● Cost/Month: 128,7 QAR ( 531,271.68 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 4,2857 QAR ( 16,602.24 LBP )
● Cost/Day: 4,29 QAR ( 16,602.24 LBP )
● Cost/Month: 128,7 QAR ( 531,271.68 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 4,2857 QAR ( 16,602.24 LBP )
● Cost/Day: 4,29 QAR ( 16,602.24 LBP )
● Cost/Month: 128,7 QAR ( 531,271.68 LBP )
Heart failure :
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Cost/Day: 4,21 AED ( 16,443.84 LBP )
● Cost/Month: 126,3 AED ( 517,980.96 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Cost/Day: 4,21 AED ( 16,443.84 LBP )
● Cost/Month: 126,3 AED ( 517,980.96 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Cost/Day: 4,21 AED ( 16,443.84 LBP )
● Cost/Month: 126,3 AED ( 517,980.96 LBP )
Heart failure :
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Cost/Day: 4,21 AED ( 16,443.84 LBP )
● Cost/Month: 126,3 AED ( 517,980.96 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Cost/Day: 4,21 AED ( 16,443.84 LBP )
● Cost/Month: 126,3 AED ( 517,980.96 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 4,2143 AED ( 16,443.84 LBP )
● Cost/Day: 4,21 AED ( 16,443.84 LBP )
● Cost/Month: 126,3 AED ( 517,980.96 LBP )
Heart failure :
● Cost/Unit: 2,7422 SEK ( 3,600.22 LBP )
● Cost/Day: 2,74 SEK ( 3,600.22 LBP )
● Cost/Month: 82,2 SEK ( 147,609.02 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 2,7422 SEK ( 3,600.22 LBP )
● Cost/Day: 2,74 SEK ( 3,600.22 LBP )
● Cost/Month: 82,2 SEK ( 147,609.02 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 2,7422 SEK ( 3,600.22 LBP )
● Cost/Day: 2,74 SEK ( 3,600.22 LBP )
● Cost/Month: 82,2 SEK ( 147,609.02 LBP )
Heart failure :
● Cost/Unit: 1,8306 NOK ( 1,730.27 LBP )
● Cost/Day: 1,83 NOK ( 1,730.27 LBP )
● Cost/Month: 54,9 NOK ( 93,434.58 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 1,8306 NOK ( 1,730.27 LBP )
● Cost/Day: 1,83 NOK ( 1,730.27 LBP )
● Cost/Month: 54,9 NOK ( 93,434.58 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 1,8306 NOK ( 1,730.27 LBP )
● Cost/Day: 1,83 NOK ( 1,730.27 LBP )
● Cost/Month: 54,9 NOK ( 93,434.58 LBP )
Heart failure :
● Cost/Unit: 2,7027 CZK ( 1,381.52 LBP )
● Cost/Day: 2,7 CZK ( 1,381.52 LBP )
● Cost/Month: 81 CZK ( 55,951.56 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 2,7027 CZK ( 1,381.52 LBP )
● Cost/Day: 2,7 CZK ( 1,381.52 LBP )
● Cost/Month: 81 CZK ( 55,951.56 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 2,7027 CZK ( 1,381.52 LBP )
● Cost/Day: 2,7 CZK ( 1,381.52 LBP )
● Cost/Month: 81 CZK ( 55,951.56 LBP )
Heart failure :
● Cost/Unit: 0,6143 EUR ( 0.00 LBP )
● Cost/Day: 0,61 EUR ( 0.00 LBP )
● Cost/Month: 18,3 EUR ( 330,840.90 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,6143 EUR ( 0.00 LBP )
● Cost/Day: 0,61 EUR ( 0.00 LBP )
● Cost/Month: 18,3 EUR ( 330,840.90 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,6143 EUR ( 0.00 LBP )
● Cost/Day: 0,61 EUR ( 0.00 LBP )
● Cost/Month: 18,3 EUR ( 330,840.90 LBP )
Heart failure :
● Cost/Unit: 0,12 EUR ( 0.00 LBP )
● Cost/Day: 0,12 EUR ( 0.00 LBP )
● Cost/Month: 3,6 EUR ( 55,140.15 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,12 EUR ( 0.00 LBP )
● Cost/Day: 0,12 EUR ( 0.00 LBP )
● Cost/Month: 3,6 EUR ( 55,140.15 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,12 EUR ( 0.00 LBP )
● Cost/Day: 0,12 EUR ( 0.00 LBP )
● Cost/Month: 3,6 EUR ( 55,140.15 LBP )
Heart failure :
● Cost/Unit: 0,2871 EUR ( 0.00 LBP )
● Cost/Day: 0,29 EUR ( 0.00 LBP )
● Cost/Month: 8,7 EUR ( 147,040.40 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2871 EUR ( 0.00 LBP )
● Cost/Day: 0,29 EUR ( 0.00 LBP )
● Cost/Month: 8,7 EUR ( 147,040.40 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2871 EUR ( 0.00 LBP )
● Cost/Day: 0,29 EUR ( 0.00 LBP )
● Cost/Month: 8,7 EUR ( 147,040.40 LBP )
Heart failure :
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Heart failure :
● Cost/Unit: 0,1426 EUR ( 0.00 LBP )
● Cost/Day: 0,14 EUR ( 0.00 LBP )
● Cost/Month: 4,2 EUR ( 73,520.20 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,1426 EUR ( 0.00 LBP )
● Cost/Day: 0,14 EUR ( 0.00 LBP )
● Cost/Month: 4,2 EUR ( 73,520.20 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,1426 EUR ( 0.00 LBP )
● Cost/Day: 0,14 EUR ( 0.00 LBP )
● Cost/Month: 4,2 EUR ( 73,520.20 LBP )
Heart failure :
● Cost/Unit: 0,4089 BHD ( 0.00 LBP )
● Cost/Day: 0,41 BHD ( 0.00 LBP )
● Cost/Month: 12,3 BHD ( 481,449.24 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4089 BHD ( 0.00 LBP )
● Cost/Day: 0,41 BHD ( 0.00 LBP )
● Cost/Month: 12,3 BHD ( 481,449.24 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4089 BHD ( 0.00 LBP )
● Cost/Day: 0,41 BHD ( 0.00 LBP )
● Cost/Month: 12,3 BHD ( 481,449.24 LBP )
Heart failure :
● Cost/Unit: 0,3196 KWD ( 0.00 LBP )
● Cost/Day: 0,32 KWD ( 0.00 LBP )
● Cost/Month: 9,6 KWD ( 446,130.72 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,3196 KWD ( 0.00 LBP )
● Cost/Day: 0,32 KWD ( 0.00 LBP )
● Cost/Month: 9,6 KWD ( 446,130.72 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,3196 KWD ( 0.00 LBP )
● Cost/Day: 0,32 KWD ( 0.00 LBP )
● Cost/Month: 9,6 KWD ( 446,130.72 LBP )
Heart failure :
● Cost/Unit: 0,4675 CHF ( 0.00 LBP )
● Cost/Day: 0,47 CHF ( 0.00 LBP )
● Cost/Month: 14,1 CHF ( 238,843.50 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4675 CHF ( 0.00 LBP )
● Cost/Day: 0,47 CHF ( 0.00 LBP )
● Cost/Month: 14,1 CHF ( 238,843.50 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4675 CHF ( 0.00 LBP )
● Cost/Day: 0,47 CHF ( 0.00 LBP )
● Cost/Month: 14,1 CHF ( 238,843.50 LBP )
Heart failure :
● Cost/Unit: 0,4886 GBP ( 0.00 LBP )
● Cost/Day: 0,49 GBP ( 0.00 LBP )
● Cost/Month: 14,7 GBP ( 282,110.78 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4886 GBP ( 0.00 LBP )
● Cost/Day: 0,49 GBP ( 0.00 LBP )
● Cost/Month: 14,7 GBP ( 282,110.78 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4886 GBP ( 0.00 LBP )
● Cost/Day: 0,49 GBP ( 0.00 LBP )
● Cost/Month: 14,7 GBP ( 282,110.78 LBP )
Heart failure :
● Cost/Unit: 0,2725 JOD ( 0.00 LBP )
● Cost/Day: 0,27 JOD ( 0.00 LBP )
● Cost/Month: 8,1 JOD ( 170,721.52 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2725 JOD ( 0.00 LBP )
● Cost/Day: 0,27 JOD ( 0.00 LBP )
● Cost/Month: 8,1 JOD ( 170,721.52 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2725 JOD ( 0.00 LBP )
● Cost/Day: 0,27 JOD ( 0.00 LBP )
● Cost/Month: 8,1 JOD ( 170,721.52 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info